J Pharm Pharmacogn Res 3(suppl. 1): S29, 2015
Proceedings of the 4th International Symposium on Pharmacology of Natural Products FAPRONATURA 2015 September 21st-25th, 2015; Cuban Society of Pharmacology. Topes de Collantes, Sancti Spiritus, Cuba.
OC-11: EFFECT OF Spirulina platensis IN PATIENTS WITH METABOLIC SYNDROME
Casamayor Z, González S, Díaz A, Conde E.
Introduction: The metabolic syndrome is an important cause of morbidity and mortality, considered a risk factor for cardiovascular disease. Carbohydrate disorders, obesity, dyslipidemia and hypertension associated characterize it. Spirulina for its high content of carotenoids and other antioxidants can benefit prevention and improvement, decreasing the blood lipid concentration and intervene in stopping the oxidative processes responsible for the deterioration of the walls of veins and arteries, improving blood pressure. Objective: To evaluate the effect of Spirulina platensis in patients with metabolic syndrome. Methods: A longitudinal, prospective study of 45 adults with a diagnosis of metabolic syndrome, who attended the medical examination control, was conducted for the period 2010-2013. They randomly assigned two groups: a control with dietary advice and one study with dietary advice plus six tablets daily Spirel® 100% natural for six months. Changes in lipid profile and IPS, were evaluated from test Wilcoxon signed ranks after treatment in each group, with alpha=0.05. Results: The decrease in cholesterol was significant in the study group (p=0.001). When compared with the control group, the t-test showed no statistically significant difference (p=0.297). Triglycerides decreased significantly in the study group (p=0.001). Both groups experienced significant changes in the IPS, in the control group values decreased (worsened) (p=0.000) and in the study group was significantly increased (p=0.000), resulted in improved peripheral vascular insufficiency. No adverse reactions were reported. Conclusions: Consumption of Spirel®100% natural for six months is effective and safe in improving metabolic syndrome and peripheral vascular insufficiency.
Citation Format: Casamayor Z, González S, Díaz A, Conde E (2015) Effect of Spirulina platensis in patients with metabolic syndrome. [Abstract]. In: Proceedings of the FAPRONATURA 2015; 2015 Sep 21-25; Topes de Collantes, Sancti Spiritus: CSF. J Pharm Pharmacogn Res 3(Suppl. 1): S29. Abstract nr OC-11.